{"id":22458,"date":"2023-12-07T23:43:29","date_gmt":"2023-12-07T22:43:29","guid":{"rendered":"https:\/\/k2info.w.uib.no\/?p=22458"},"modified":"2023-12-07T23:43:29","modified_gmt":"2023-12-07T22:43:29","slug":"funding-opportunities-for-k2","status":"publish","type":"post","link":"https:\/\/k2info.w.uib.no\/en\/2023\/12\/07\/funding-opportunities-for-k2\/","title":{"rendered":"Funding Opportunities for K2"},"content":{"rendered":"

[:no]Many funding organisations have recently announced new calls for funding for the spring. We want to guide you through the jungle and have curated a list for researchers at K2. But there and there are more calls at the homepage of the research advisors at the Faculty: Application Support for External Funding | Faculty of Medicine | UiB<\/a>.<\/p>\n

If you plan to apply for funding, we appreciate if you inform the Department via this form:: Varsel om s\u00f8knad om ekstern finansiering \/ Intention to apply for external funding (uib.no)<\/a>. Happy Grant Writing!<\/p>\n

Meltzer fond<\/strong><\/a>
\n150.000 NOK, for UiB employees. Travel, running costs, organising conferences etc.
\nDeadline: annual, next: 12 January 2024<\/strong><\/p>\n

ERA4Health\u00a0<\/strong>Modulation of brain ageing through nutrition and healthy lifestyle (NutriBrain)<\/a><\/strong>
\nTransnational calls with 3-5 partners,\u00a036 months. Funding: 300.000 EUR for the Norwegian participants (400.000 for coordinators). The other partners receive funding from their national funders.\u00a0On the improvement of cognitive brain ageing through nutrition and other lifestyle factors.
\nDeadline (pre proposals): 15 January 2024<\/strong><\/p>\n

Novo Nordisk Endocrinology\u00a0and Metabolism<\/strong>
\n–\u00a0\u00a0<\/strong>Excellence Emerging Investigator Grant Endocrinology and Metabolism<\/a><\/strong>
\n10 MIO DKK, 5 years. For researchers at 4-8 years after PhD.<\/p>\n

–Ascending Investigator Grant<\/a>. 5 years, 10 MIO DKK. For researcher 7-18 years after PhD. Prevention of disease relevant to the human organism within the areas of endocrinology and metabolism, relating to cellular energy homeostasis, and hormonal disorders of the endocrine system.
\n–\u00a0Distinguished Investigator Grant<\/a>. 5 years 10 MIO DKK.
\nDeadline: 16 January 2024\u00a0<\/strong><\/p>\n

ERA4Health <\/strong>Nano and advanced technologies for disease prevention, diagnostic and therapy (NANOTECMEC)<\/a><\/strong>
\n3-5 partners, 3 countries, 3 MNOK for the Norwegian participant. Regenerative medicine, Diagnostics or Nanotherapy. TRL3-6. The aim of the call is to advance nanomedicine toward any translational focus with anticipated impact relative to the risk and investment.
\nDeadline (pre proposals): 30 January 2024<\/strong><\/p>\n

Global Initiative on Chronic Diseases \/ NIH\u00a0<\/strong>Primary and Secondary Prevention of Cancer<\/a><\/strong>
\nBudget not limited, 5 years. Implementation research in Low- and Middle-Income Countries or in populations facing conditions of vulnerability in High-Income Countries.
\nDeadline: 05 February 2024<\/strong><\/p>\n

DAM Foundation\u00a0<\/strong>Research grants (Forskning)<\/a><\/strong>
\n1,5-3 MIO NOK for 3 years. Stiftelsen Dam is one of Norway’s largest foundations and provides funding for health and research projects that will provide better health through participation and activity for people in Norway. The applications are sent through a volunteer oganisation like the Norwegian Red Cross, The Norwegian Cancer Society, the National Association for Publich Health etc.
\nDeadline: annually, 15 February<\/strong><\/p>\n

ERA PerMed\u00a0<\/strong>PMTargets<\/a><\/strong>
\nJoint Transnational Call, most likely 3-5 partners from at least 3 countries, 300.000 EUR for the Norwegian partners. Topic: Identification or Validation of Targets for Personalised Medicine Approaches. Must combine the research on new and advanced targets with companion biomarker research (companion diagnostics).
\nDeadline: 5 March 2024<\/strong>\u00a0<\/strong><\/p>\n

NFR\u00a0<\/strong>Collaborative Projects Food-Climate-Health<\/a><\/strong>
\n12 MIO NOK, 4 years. Requires collaboration with partners in other sectors.
\nThe projects must be interdisciplinary and cross-sectoral. They must include elements from each of these three areas and look at the relationships and interaction effects between them:
\n–\u00a0food (sea and\/or land-based)
\n–\u00a0environment and\/or climate
\n–\u00a0public health
\nDeadline: 13 March 2024<\/strong><\/p>\n

NFR Collaborative Projects\u00a0<\/strong>Enabling Technologies<\/a><\/strong>
\n12 MIO NOK, 4 years. Requires collaboration with partners in other sectors.
\n– Industrial Biotechnology. Biotechnological methods, enzymes, microorganisms and other cell systems to produce various products, such as pharmaceuticals, chemicals, feed, textiles and energy.
\n– Technology convergence. Create radically new technologies through professional fusion within the enabling technologies.
\nDeadline: 13 March 2024<\/strong><\/p>\n

JPIAMR\u00a0<\/strong>AMR Interventions 2024<\/a><\/strong>
\n3-7 Partners from 3 countries. Probably 300.000 EUR for the Norwegian partners; other partners are funded by their national funders.
\nTopic 1:<\/strong>\u00a0Design novel or improved interventions to prevent, mitigate and \/or treat fungal infections, which are resistant to treatments and\/or are at risk of developing resistance
\nTopic 2:<\/strong>\u00a0Improve and\/or, compare and\/or evaluate strategies, technologies, treatments, methods, protocols or data collection based on existing \u00a0interventions, aiming to prevent or reduce the emergence or spread of antibacterial or antifungal resistance or to treat\/cure infections caused by resistant bacteria\/fungi and recommend new policies.
\nDeadline (preproposals): 14 March 2024<\/strong><\/p>\n

HKDir <\/strong>UTFORSK<\/a><\/strong>
\n3 MNOK, 4 years. The Norwegian Directorate for Higher education and skills finances these educational projects with Brazil, Canada, China, India, Japan, South Africa, South Korea, or the USA.
\nDeadline: 15 April 2024<\/strong><\/p>\n

Innovative Health Initiative\u00a0<\/strong>Call 6 and 7<\/a><\/strong>
\nThe Innovative Health Initiative (IHI) is a public-private partnership between the European Union and the European life science industries that funds health research and innovation to address unmet public health needs and foster interdisciplinary and international collaboration. Upcoming topics:
\n–\u00a06.1: Support healthcare system resilience through a focus on persistency in the treatment of chronic diseases<\/strong>. 60 months. The pre-defined industry consortium will contribute 11 MIO EUR. IHI will contribute 11 MIO EUR.\u00a0This budget is expected to cover four pilots in different disease areas (including diabetes, obesity, and cardiovascular disease) in different geographies and healthcare systems.
\n–\u00a06.2: Development of practical guidance and recommendations for using real world data\/real world evidence in healthcare decision-making. 60 montsh.\u00a0<\/strong>Pre-defined industry consortium will contribute 13 MIO EUR. IHI contributes 13 MIO EUR.
\n–\u00a07.1 Improving clinical management of heart disease from early detection to treatment<\/strong>. 12,5 MIO EUR.
\n–\u00a07.2 User-centric technologies and optimised hospital workflows for a sustainable healthcare workforce.\u00a0<\/strong>12,5 MIO EUR
\n– 7.3 Clinical validation of biomarkers for diagnosis, monitoring disease progression and treatment response<\/strong>.\u00a0\u00a015 MIO EUR.
\nDeadline: summer 2024<\/strong><\/p>\n

\"\"<\/a>[:en]Many funding organisations have recently announced new calls for funding for the spring. We want to guide you through the jungle and have curated a list for researchers at K2. But there and there are more calls at the homepage of the research advisors at the Faculty: Application Support for External Funding | Faculty of Medicine | UiB<\/a>.<\/p>\n

If you plan to apply for funding, we appreciate if you inform the Department via this form:: Varsel om s\u00f8knad om ekstern finansiering \/ Intention to apply for external funding (uib.no)<\/a>. Happy Grant Writing!<\/p>\n

Meltzer fond<\/strong><\/a>
\n150.000 NOK, for UiB employees. Travel, running costs, organising conferences etc.
\nDeadline: annual, next: 12 January 2024<\/strong><\/p>\n

ERA4Health\u00a0<\/strong>Modulation of brain ageing through nutrition and healthy lifestyle (NutriBrain)<\/a><\/strong>
\nTransnational calls with 3-5 partners,\u00a036 months. Funding: 300.000 EUR for the Norwegian participants (400.000 for coordinators). The other partners receive funding from their national funders.\u00a0On the improvement of cognitive brain ageing through nutrition and other lifestyle factors.
\nDeadline (pre proposals): 15 January 2024<\/strong><\/p>\n

\u00a0<\/strong>Novo Nordisk Endocrinology\u00a0and Metabolism<\/strong>
\n–\u00a0\u00a0<\/strong>Excellence Emerging Investigator Grant Endocrinology and Metabolism<\/a><\/strong>
\n10 MIO DKK, 5 years. For researchers at 4-8 years after PhD.<\/p>\n

–Ascending Investigator Grant<\/a>. 5 years, 10 MIO DKK. For researcher 7-18 years after PhD. Prevention of disease relevant to the human organism within the areas of endocrinology and metabolism, relating to cellular energy homeostasis, and hormonal disorders of the endocrine system.
\n–\u00a0Distinguished Investigator Grant<\/a>. 5 years 10 MIO DKK.
\nDeadline: 16 January 2024\u00a0<\/strong><\/p>\n

ERA4Health <\/strong>Nano and advanced technologies for disease prevention, diagnostic and therapy (NANOTECMEC)<\/a><\/strong>
\n3-5 partners, 3 countries, 3 MNOK for the Norwegian participant. Regenerative medicine, Diagnostics or Nanotherapy. TRL3-6. The aim of the call is to advance nanomedicine toward any translational focus with anticipated impact relative to the risk and investment.
\nDeadline (pre proposals): 30 January 2024<\/strong><\/p>\n

Global Initiative on Chronic Diseases \/ NIH\u00a0<\/strong>Primary and Secondary Prevention of Cancer<\/a><\/strong>
\nBudget not limited, 5 years. Implementation research in Low- and Middle-Income Countries or in populations facing conditions of vulnerability in High-Income Countries.
\nDeadline: 05 February 2024<\/strong><\/p>\n

DAM Foundation\u00a0<\/strong>Research grants (Forskning)<\/a><\/strong>
\n1,5-3 MIO NOK for 3 years. Stiftelsen Dam is one of Norway’s largest foundations and provides funding for health and research projects that will provide better health through participation and activity for people in Norway. The applications are sent through a volunteer oganisation like the Norwegian Red Cross, The Norwegian Cancer Society, the National Association for Publich Health etc.
\nDeadline: annually, 15 February<\/strong><\/p>\n

ERA PerMed\u00a0<\/strong>PMTargets<\/a><\/strong>
\nJoint Transnational Call, most likely 3-5 partners from at least 3 countries, 300.000 EUR for the Norwegian partners. Topic: Identification or Validation of Targets for Personalised Medicine Approaches. Must combine the research on new and advanced targets with companion biomarker research (companion diagnostics).
\nDeadline: 5 March 2024<\/strong><\/p>\n

NFR\u00a0<\/strong>Collaborative Projects Food-Climate-Health<\/a><\/strong>
\n12 MIO NOK, 4 years. Requires collaboration with partners in other sectors.
\nThe projects must be interdisciplinary and cross-sectoral. They must include elements from each of these three areas and look at the relationships and interaction effects between them:
\n–\u00a0food (sea and\/or land-based)
\n–\u00a0environment and\/or climate
\n–\u00a0public health
\nDeadline: 13 March 2024<\/strong><\/p>\n

NFR Collaborative Projects\u00a0<\/strong>Enabling Technologies<\/a><\/strong>
\n12 MIO NOK, 4 years. Requires collaboration with partners in other sectors.
\n– Industrial Biotechnology. Biotechnological methods, enzymes, microorganisms and other cell systems to produce various products, such as pharmaceuticals, chemicals, feed, textiles and energy.
\n– Technology convergence. Create radically new technologies through professional fusion within the enabling technologies.
\nDeadline: 13 March 2024<\/strong><\/p>\n

JPIAMR\u00a0<\/strong>AMR Interventions 2024<\/a><\/strong>
\n3-7 Partners from 3 countries. Probably 300.000 EUR for the Norwegian partners; other partners are funded by their national funders.
\nTopic 1:<\/strong>\u00a0Design novel or improved interventions to prevent, mitigate and \/or treat fungal infections, which are resistant to treatments and\/or are at risk of developing resistance
\nTopic 2:<\/strong>\u00a0Improve and\/or, compare and\/or evaluate strategies, technologies, treatments, methods, protocols or data collection based on existing \u00a0interventions, aiming to prevent or reduce the emergence or spread of antibacterial or antifungal resistance or to treat\/cure infections caused by resistant bacteria\/fungi and recommend new policies.
\nDeadline (preproposals): 14 March 2024<\/strong><\/p>\n

HKDir <\/strong>UTFORSK<\/a><\/strong>
\n3 MNOK, 4 years. The Norwegian Directorate for Higher education and skills finances these educational projects with Brazil, Canada, China, India, Japan, South Africa, South Korea, or the USA.
\nDeadline: 15 April 2024<\/strong><\/p>\n

Innovative Health Initiative\u00a0<\/strong>Call 6 and 7<\/a><\/strong>
\nThe Innovative Health Initiative (IHI) is a public-private partnership between the European Union and the European life science industries that funds health research and innovation to address unmet public health needs and foster interdisciplinary and international collaboration. Upcoming topics:
\n–\u00a06.1: Support healthcare system resilience through a focus on persistency in the treatment of chronic diseases<\/strong>. 60 months. The pre-defined industry consortium will contribute 11 MIO EUR. IHI will contribute 11 MIO EUR.\u00a0This budget is expected to cover four pilots in different disease areas (including diabetes, obesity, and cardiovascular disease) in different geographies and healthcare systems.
\n–\u00a06.2: Development of practical guidance and recommendations for using real world data\/real world evidence in healthcare decision-making. 60 montsh.\u00a0<\/strong>Pre-defined industry consortium will contribute 13 MIO EUR. IHI contributes 13 MIO EUR.
\n–\u00a07.1 Improving clinical management of heart disease from early detection to treatment<\/strong>. 12,5 MIO EUR.
\n–\u00a07.2 User-centric technologies and optimised hospital workflows for a sustainable healthcare workforce.\u00a0<\/strong>12,5 MIO EUR
\n– 7.3 Clinical validation of biomarkers for diagnosis, monitoring disease progression and treatment response<\/strong>.\u00a0\u00a015 MIO EUR.
\nDeadline: summer 2024<\/strong><\/p>\n

\"\"<\/a>[:]<\/p>\n","protected":false},"excerpt":{"rendered":"

[:no]Many funding organisations have recently announced new calls for funding for the spring. We want to guide you through the jungle and have curated a list for researchers at K2. But there and there are more calls at the homepage…<\/p>\n

Read more →<\/a><\/p>\n","protected":false},"author":5236,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[44],"tags":[],"class_list":["post-22458","post","type-post","status-publish","format-standard","hentry","category-nyheter"],"_links":{"self":[{"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/posts\/22458","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/users\/5236"}],"replies":[{"embeddable":true,"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/comments?post=22458"}],"version-history":[{"count":1,"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/posts\/22458\/revisions"}],"predecessor-version":[{"id":22460,"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/posts\/22458\/revisions\/22460"}],"wp:attachment":[{"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/media?parent=22458"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/categories?post=22458"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/tags?post=22458"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}